nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADP: the missing link between thrombosis and hemolysis
|
Gerber, Gloria F. |
|
|
7 |
20 |
p. 6364-6366 |
artikel |
2 |
A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD
|
Cronin, Robert M. |
|
|
7 |
20 |
p. 6184-6190 |
artikel |
3 |
Alquezar-Artieda N, Kuzilkova D, Roberts J, et al. Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy. Blood Adv. 2023;7(10):2228-2236.
|
|
|
|
7 |
20 |
p. 6023 |
artikel |
4 |
An in vitro model of human hematopoiesis identifies a regulatory role for the aryl hydrocarbon receptor
|
Khan, D M Isha Olive |
|
|
7 |
20 |
p. 6253-6265 |
artikel |
5 |
A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins
|
West, Robert R. |
|
|
7 |
20 |
p. 6351-6363 |
artikel |
6 |
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
|
O’Neal, Julie |
|
|
7 |
20 |
p. 6009-6022 |
artikel |
7 |
Cardiac involvement resolution is frequent and associated with improved outcome in Erdheim-Chester disease
|
Azoulay, Lévi-Dan |
|
|
7 |
20 |
p. 6130-6133 |
artikel |
8 |
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL
|
Epperly, Rebecca |
|
|
7 |
20 |
p. 6320-6324 |
artikel |
9 |
Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma
|
Wachsmann, Tassilo L. A. |
|
|
7 |
20 |
p. 6178-6183 |
artikel |
10 |
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL
|
Davies, John R. |
|
|
7 |
20 |
p. 6156-6162 |
artikel |
11 |
Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception
|
Bala, Natasha S. |
|
|
7 |
20 |
p. 6140-6150 |
artikel |
12 |
Complement and platelets: prothrombotic cell activation requires membrane attack complex–induced release of danger signals
|
Mannes, Marco |
|
|
7 |
20 |
p. 6367-6380 |
artikel |
13 |
Defining a cohort of anemia-activated cis elements reveals a mechanism promoting erythroid precursor function
|
Zhou, Yichao |
|
|
7 |
20 |
p. 6325-6338 |
artikel |
14 |
Digital pathology in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: correlation with treatment response
|
Sereda, Sergej |
|
|
7 |
20 |
p. 6285-6289 |
artikel |
15 |
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
|
Gorak, Edward J. |
|
|
7 |
20 |
p. 6120-6129 |
artikel |
16 |
Editorial Board
|
|
|
|
7 |
20 |
p. i |
artikel |
17 |
Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
|
Abdullahi, Shehu U. |
|
|
7 |
20 |
p. 6024-6034 |
artikel |
18 |
Free interleukin-18 is elevated in CD22 CAR T-cell–associated hemophagocytic lymphohistiocytosis–like toxicities
|
Rocco, Joseph M. |
|
|
7 |
20 |
p. 6134-6139 |
artikel |
19 |
Front Matter
|
|
|
|
7 |
20 |
p. ii |
artikel |
20 |
High-throughput microfluidic blood testing to phenotype genetically linked platelet disorders: an aid to diagnosis
|
Fernandez, Delia I. |
|
|
7 |
20 |
p. 6163-6177 |
artikel |
21 |
More intensive therapy has a better effect for frail parents with multiple myeloma
|
DuMontier, Clark |
|
|
7 |
20 |
p. 6275-6284 |
artikel |
22 |
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study
|
Olszewski, Adam J. |
|
|
7 |
20 |
p. 6055-6065 |
artikel |
23 |
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
|
Popat, Uday R. |
|
|
7 |
20 |
p. 6196-6205 |
artikel |
24 |
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study
|
Ansell, Stephen M. |
|
|
7 |
20 |
p. 6266-6274 |
artikel |
25 |
Off-the-shelf CAR–engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia
|
Mansour, Anthony G. |
|
|
7 |
20 |
p. 6225-6239 |
artikel |
26 |
Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
|
Schubert, Maria-Luisa |
|
|
7 |
20 |
p. 6191-6195 |
artikel |
27 |
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis
|
Gustine, Joshua N. |
|
|
7 |
20 |
p. 6080-6091 |
artikel |
28 |
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
|
Brown-Burke, Fiona |
|
|
7 |
20 |
p. 6211-6224 |
artikel |
29 |
Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia
|
Cao, Linlin |
|
|
7 |
20 |
p. 6240-6252 |
artikel |
30 |
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories
|
Borate, Uma |
|
|
7 |
20 |
p. 6048-6054 |
artikel |
31 |
Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH
|
Zijtregtop, Eline A. M. |
|
|
7 |
20 |
p. 6303-6319 |
artikel |
32 |
Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo
|
Jongejan, Yvonne K. |
|
|
7 |
20 |
p. 6108-6119 |
artikel |
33 |
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
|
Homan, Claire C. |
|
|
7 |
20 |
p. 6092-6107 |
artikel |
34 |
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
|
Haverkos, Bradley |
|
|
7 |
20 |
p. 6339-6350 |
artikel |
35 |
The fate of mitochondria during platelet activation
|
Grichine, Alexei |
|
|
7 |
20 |
p. 6290-6302 |
artikel |
36 |
The overlap of skin and blood T-cell clones in early-stage mycosis fungoides
|
Joffe, Daniel |
|
|
7 |
20 |
p. 6206-6210 |
artikel |
37 |
Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
|
Kanaan, Sami B. |
|
|
7 |
20 |
p. 6066-6079 |
artikel |
38 |
Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma
|
Gudgeon, Nancy |
|
|
7 |
20 |
p. 6035-6047 |
artikel |
39 |
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome
|
Ding, Yanna |
|
|
7 |
20 |
p. 6151-6155 |
artikel |